Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Docetaxel, Cisplatin and 5-FU in Oral Cavity SCC
NCT00400205Phase 2Terminated
- Sponsor
- Emory University
- Start
- Aug 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in squamous cell carcinoma of the oral cavity (OSCC), sponsored by Emory University. Primary endpoint: Number of Patients Who Had Response by RECIST Criteria. Started Aug 2006; status: terminated.
02
Drugs
docetaxel
03
Conditions
squamous cell carcinoma of the oral cavity (OSCC)
Beyond the preview
Go deeper on NCT00400205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400205.